278 related articles for article (PubMed ID: 34935874)
1. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.
Shakiba M; Zumbo P; Espinosa-Carrasco G; Menocal L; Dündar F; Carson SE; Bruno EM; Sanchez-Rivera FJ; Lowe SW; Camara S; Koche RP; Reuter VP; Socci ND; Whitlock B; Tamzalit F; Huse M; Hellmann MD; Wells DK; Defranoux NA; Betel D; Philip M; Schietinger A
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34935874
[TBL] [Abstract][Full Text] [Related]
2. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
3. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A
Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral CD8
Horton BL; Williams JB; Cabanov A; Spranger S; Gajewski TF
Cancer Immunol Res; 2018 Jan; 6(1):14-24. PubMed ID: 29097422
[TBL] [Abstract][Full Text] [Related]
5. The Antitumor Effects of Vaccine-Activated CD8
Wu S; Zhu W; Peng Y; Wang L; Hong Y; Huang L; Dong D; Xie J; Merchen T; Kruse E; Guo ZS; Bartlett D; Fu N; He Y
Cancer Immunol Res; 2017 Oct; 5(10):908-919. PubMed ID: 28851693
[TBL] [Abstract][Full Text] [Related]
6. Increased diversity with reduced "diversity evenness" of tumor infiltrating T-cells for the successful cancer immunotherapy.
Hosoi A; Takeda K; Nagaoka K; Iino T; Matsushita H; Ueha S; Aoki S; Matsushima K; Kubo M; Morikawa T; Kitaura K; Suzuki R; Kakimi K
Sci Rep; 2018 Jan; 8(1):1058. PubMed ID: 29348598
[TBL] [Abstract][Full Text] [Related]
7. Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor.
Pasetto A; Gros A; Robbins PF; Deniger DC; Prickett TD; Matus-Nicodemos R; Douek DC; Howie B; Robins H; Parkhurst MR; Gartner J; Trebska-McGowan K; Crystal JS; Rosenberg SA
Cancer Immunol Res; 2016 Sep; 4(9):734-43. PubMed ID: 27354337
[TBL] [Abstract][Full Text] [Related]
8. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
9. Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cells.
Ichiki Y; Shigematsu Y; Baba T; Shiota H; Fukuyama T; Nagata Y; So T; Yasuda M; Takenoyama M; Yasumoto K
Cancer Sci; 2020 Nov; 111(11):4021-4030. PubMed ID: 32780528
[TBL] [Abstract][Full Text] [Related]
10. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
Reiser J; Banerjee A
J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
[TBL] [Abstract][Full Text] [Related]
11. Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens.
Jæhger DE; Hübbe ML; Kræmer MK; Clergeaud G; Olsen AV; Stavnsbjerg C; Wiinholt MN; Kjær A; Henriksen JR; Hansen AE; Andresen TL
Sci Rep; 2021 Oct; 11(1):19794. PubMed ID: 34611284
[TBL] [Abstract][Full Text] [Related]
12. TCR repertoires of intratumoral T-cell subsets.
Linnemann C; Mezzadra R; Schumacher TN
Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
14. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.
Morgan RA; Dudley ME; Yu YY; Zheng Z; Robbins PF; Theoret MR; Wunderlich JR; Hughes MS; Restifo NP; Rosenberg SA
J Immunol; 2003 Sep; 171(6):3287-95. PubMed ID: 12960359
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted Role of BTLA in the Control of CD8
Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
[No Abstract] [Full Text] [Related]
16. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
17. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
18. TOX is a critical regulator of tumour-specific T cell differentiation.
Scott AC; Dündar F; Zumbo P; Chandran SS; Klebanoff CA; Shakiba M; Trivedi P; Menocal L; Appleby H; Camara S; Zamarin D; Walther T; Snyder A; Femia MR; Comen EA; Wen HY; Hellmann MD; Anandasabapathy N; Liu Y; Altorki NK; Lauer P; Levy O; Glickman MS; Kaye J; Betel D; Philip M; Schietinger A
Nature; 2019 Jul; 571(7764):270-274. PubMed ID: 31207604
[TBL] [Abstract][Full Text] [Related]
19. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
20. CD8
van der Leun AM; Thommen DS; Schumacher TN
Nat Rev Cancer; 2020 Apr; 20(4):218-232. PubMed ID: 32024970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
